107 related articles for article (PubMed ID: 1526369)
1. Covalent protein modifications and gene expression changes in rodent liver following administration of methapyrilene: a study using two-dimensional electrophoresis.
Anderson NL; Copple DC; Bendele RA; Probst GS; Richardson FC
Fundam Appl Toxicol; 1992 May; 18(4):570-80. PubMed ID: 1526369
[TBL] [Abstract][Full Text] [Related]
2. Dose-responses in rat hepatic protein modification and expression following exposure to the rat hepatocarcinogen methapyrilene.
Richardson FC; Horn DM; Anderson NL
Carcinogenesis; 1994 Feb; 15(2):325-9. PubMed ID: 8313526
[TBL] [Abstract][Full Text] [Related]
3. The hepatocarcinogen methapyrilene but not the analog pyrilamine induces sustained hepatocellular replication and protein alterations in F344 rats in a 13-week feed study.
Cunningham ML; Pippin LL; Anderson NL; Wenk ML
Toxicol Appl Pharmacol; 1995 Apr; 131(2):216-23. PubMed ID: 7716764
[TBL] [Abstract][Full Text] [Related]
4. NTP Hepatotoxicity Studies of the Liver Carcinogen Methapyrilene Hydrochloride (CAS No. 135-23-9) Administered in Feed to Male F344/N Rats.
Toxic Rep Ser; 2000 Feb; 46():1-C7. PubMed ID: 11986676
[TBL] [Abstract][Full Text] [Related]
5. Comparisons of protein changes in human and rodent hepatocytes induced by the rat-specific carcinogen, methapyrilene.
Richardson FC; Strom SC; Copple DM; Bendele RA; Probst GS; Anderson NL
Electrophoresis; 1993; 14(1-2):157-61. PubMed ID: 8462508
[TBL] [Abstract][Full Text] [Related]
6. Editor's Highlight: Organ-Specific Epigenetic Changes Induced by the Nongenotoxic Liver Carcinogen Methapyrilene in Fischer 344 Rats.
Shpyleva S; Dreval K; de Conti A; Kindrat I; Melnyk S; Yan J; Chen T; Beland FA; Pogribny IP
Toxicol Sci; 2017 Mar; 156(1):190-198. PubMed ID: 28013212
[TBL] [Abstract][Full Text] [Related]
7. Examination of genotoxicity, toxicity and morphologic alterations in hepatocytes following in vivo or in vitro exposure to methapyrilene.
Steinmetz KL; Tyson CK; Meierhenry EF; Spalding JW; Mirsalis JC
Carcinogenesis; 1988 Jun; 9(6):959-63. PubMed ID: 3370759
[TBL] [Abstract][Full Text] [Related]
8. Effects of methapyrilene measured in mitochondria isolated from naive and methapyrilene-treated rat and mouse hepatocytes.
Copple DM; Rush GF; Richardson FC
Toxicol Appl Pharmacol; 1992 Sep; 116(1):10-6. PubMed ID: 1529442
[TBL] [Abstract][Full Text] [Related]
9. The carcinogenic effect of methapyrilene combined with nitrosodiethylamine given to rats in low doses.
Lijinsky W; Kovatch RM; Thomas BJ
Carcinogenesis; 1992 Jul; 13(7):1293-7. PubMed ID: 1638702
[TBL] [Abstract][Full Text] [Related]
10. Carcinogenesis by nonmutagenic chemicals: early response of rat liver cells induced by methapyrilene.
Iype PT; Bucana CD; Kelley SP
Cancer Res; 1985 May; 45(5):2184-91. PubMed ID: 2985247
[TBL] [Abstract][Full Text] [Related]
11. The evaluation of methapyrilene for bacterial mutation with metabolic activation by Aroclor-induced, methapyrilene-induced and noninduced rat-liver S9.
Oberly TJ; Scheuring JC; Richardson KA; Richardson FC; Garriott ML
Mutat Res; 1993 Apr; 299(2):77-84. PubMed ID: 7680426
[TBL] [Abstract][Full Text] [Related]
12. Two-dimensional electrophoretic analysis of compartment-specific hepatic protein charge modification induced by thioacetamide exposure in rats.
Witzmann FA; Fultz CD; Mangipudy RS; Mehendale HM
Fundam Appl Toxicol; 1996 May; 31(1):124-32. PubMed ID: 8998948
[TBL] [Abstract][Full Text] [Related]
13. A sequential study of methapyrilene hydrochloride-induced liver carcinogenesis in male F344 rats.
Ohshima M; Ward JM; Brennan LM; Creasia DA
J Natl Cancer Inst; 1984 Mar; 72(3):759-68. PubMed ID: 6583458
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation and oncogene expression in methapyrilene-induced rat liver tumors and in treated hepatocytes in culture.
Hernandez L; Petropoulos CJ; Hughes SH; Lijinsky W
Mol Carcinog; 1991; 4(3):203-9. PubMed ID: 2064726
[TBL] [Abstract][Full Text] [Related]
15. Methapyrilene hepatotoxicity is associated with oxidative stress, mitochondrial disfunction and is prevented by the Ca2+ channel blocker verapamil.
Ratra GS; Morgan WA; Mullervy J; Powell CJ; Wright MC
Toxicology; 1998 Sep; 130(2-3):79-93. PubMed ID: 9865476
[TBL] [Abstract][Full Text] [Related]
16. Genotoxicity, toxicity, and carcinogenicity of the antihistamine methapyrilene.
Mirsalis JC
Mutat Res; 1987 May; 185(3):309-17. PubMed ID: 3553919
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics explain in vivo/in vitro discrepancies of carcinogen-induced gene expression alterations in rat liver and cultivated hepatocytes.
Schug M; Stöber R; Heise T; Mielke H; Gundert-Remy U; Godoy P; Reif R; Blaszkewicz M; Ellinger-Ziegelbauer H; Ahr HJ; Selinski S; Günther G; Marchan R; Blaszkewicz M; Sachinidis A; Nüssler A; Oberemm A; Hengstler JG
Arch Toxicol; 2013 Feb; 87(2):337-45. PubMed ID: 23274394
[TBL] [Abstract][Full Text] [Related]
18. Neoplastic conversion in rat liver by the antihistamine methapyrilene demonstrated by a sequential syncarcinogenic effect with N-2-fluorenylacetamide.
Furuya K; Williams GM
Toxicol Appl Pharmacol; 1984 Jun; 74(1):63-9. PubMed ID: 6729822
[TBL] [Abstract][Full Text] [Related]
19. Glutathione and lipid peroxide levels in rat liver following administration of methapyrilene and analogs.
Hernandez L; Lijinsky W
Chem Biol Interact; 1989; 69(2-3):217-24. PubMed ID: 2564814
[TBL] [Abstract][Full Text] [Related]
20. Methapyrilene toxicity: anchorage of pathologic observations to gene expression alterations.
Hamadeh HK; Knight BL; Haugen AC; Sieber S; Amin RP; Bushel PR; Stoll R; Blanchard K; Jayadev S; Tennant RW; Cunningham ML; Afshari CA; Paules RS
Toxicol Pathol; 2002; 30(4):470-82. PubMed ID: 12187938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
